Data / Medical devices / United States / Deka Research & Development Corp.
Deka Research & Development Corp.: FDA-registered device maker in Manchester, NH, United States, 20 510(k) clearances
Deka Research & Development Corp. is registered with the FDA (registration 1220973) in Manchester, NH, United States. It lists 12 device types. The FDA files 20 510(k) clearances under its listings, the newest dated October 15, 2026. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 1220973
- Address
- 340 Commercial St, Manchester, NH, United States, 03101
- Owner or operator
- DEKA Research & Development Corp. (10041884)
- Roles
- Specification developer
- First device listed
- September 13, 2012
- Registered through
- 2027
- Brand names listed
- DEKA Arm System, DEKA TAC Device, Volumetric Infusion Controller, iBOT, iBOT Personal Mobility Device (iBOT PMD), twiist AID System, twiist Automated Insulin Delivery (AID) System Powered by Tidepool, twiist Loop and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| October 15, 2026 | K262576 | twiist Loop Algorithm | QJI | Substantially Equivalent | Deka Research and Development Corp. | accessdata.fda.gov |
| June 17, 2026 | K261672 | twiist Automated Insulin Delivery (AID) System | QFG | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| August 1, 2025 | K243841 | Sparta Infusion Set for Insulin | FPA | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| April 2, 2025 | K250930 | twiist system | QFG | Substantially Equivalent | Deka Research & Development Corp. | accessdata.fda.gov |
| March 11, 2025 | K250357 | RemunityPRO Pump for Remodulin® (treprostinil) Injection | FRN | Substantially Equivalent | Deka Research & Development Corp. | accessdata.fda.gov |
| January 30, 2025 | K243442 | iBOT® PMD | IMK | Substantially Equivalent | Mobius Mobility | accessdata.fda.gov |
| January 16, 2025 | K241736 | Remunity 2.0 Pump for Remodulin (treprostinil) Injection | FRN | Substantially Equivalent | Deka Research and Development Corp. | accessdata.fda.gov |
| November 27, 2024 | K243354 | Remunity System | QJY | Substantially Equivalent | Deka Research & Development Corp. | accessdata.fda.gov |
| October 7, 2024 | K242693 | DEKA Infusion System, DEKA Administration Set | LDR | Substantially Equivalent | Deka Research and Development Corporation | accessdata.fda.gov |
| May 24, 2024 | K241178 | DEKA ACE Pump System | QFG | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| March 13, 2024 | K234055 | DEKA Loop | QJI | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| July 25, 2023 | K213536 | DEKA ACE Pump System | QFG | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| June 16, 2021 | K210920 | iBOT Personal Mobility Device (iBOT PMD) | IMK | Substantially Equivalent | Mobius Mobility | accessdata.fda.gov |
| December 30, 2020 | K202690 | Remunity Pump for Remodulin (treprostinil) Injection | QJY | Substantially Equivalent | Deka Research and Development | accessdata.fda.gov |
| February 21, 2020 | K191313 | Unity Subcutaneous Infusion System for Remodulin | QJY | Substantially Equivalent | DEKA Research & Development | accessdata.fda.gov |
| May 6, 2019 | K190182 | Unity Subcutaneous Delivery System for Remodulin | FRN | Substantially Equivalent | DEKA Research & Development | accessdata.fda.gov |
| March 2, 2018 | K172601 | Next Generation iBOT | IMK | Substantially Equivalent | Deka Research & Development Corp. | accessdata.fda.gov |
| October 3, 2016 | K153760 | Volumetric Infusion Controller | LDR | Substantially Equivalent | DEKA Research & Development | accessdata.fda.gov |
| May 9, 2014 | DEN120016 | DEKA ARM SYSTEM | PAE | Unknown | Deka Integrated Solutions Corporation | accessdata.fda.gov |
| August 23, 2011 | K093915 | DEKA TAC DEVICE | FIG | Substantially Equivalent | Deka Research & Development Corp. | accessdata.fda.gov |
Compare with other makers
- All makers of Wheelchair, Powered
- All makers of Insulin Pump Secondary Display
- All makers of Interoperable Automated Glycemic Controller
- All makers of Controller, Infusion, Intravascular, Electronic
- All makers of Set, Administration, Intravascular
Updated October 15, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.